Gut microbiota and oleoylethanolamide in the regulation of intestinal homeostasis
- PMID: 37091842
- PMCID: PMC10113643
- DOI: 10.3389/fendo.2023.1135157
Gut microbiota and oleoylethanolamide in the regulation of intestinal homeostasis
Abstract
A vast literature strongly suggests that the endocannabinoid (eCB) system and related bioactive lipids (the paracannabinoid system) contribute to numerous physiological processes and are involved in pathological conditions such as obesity, type 2 diabetes, and intestinal inflammation. The gut paracannabinoid system exerts a prominent role in gut physiology as it affects motility, permeability, and inflammatory responses. Another important player in the regulation of host metabolism is the intestinal microbiota, as microorganisms are indispensable to protect the intestine against exogenous pathogens and potentially harmful resident microorganisms. In turn, the composition of the microbiota is regulated by intestinal immune responses. The intestinal microbial community plays a fundamental role in the development of the innate immune system and is essential in shaping adaptive immunity. The active interplay between microbiota and paracannabinoids is beginning to appear as potent regulatory system of the gastrointestinal homeostasis. In this context, oleoylethanolamide (OEA), a key component of the physiological systems involved in the regulation of dietary fat consumption, energy homeostasis, intestinal motility, and a key factor in modulating eating behavior, is a less studied lipid mediator. In the small intestine namely duodenum and jejunum, levels of OEA change according to the nutrient status as they decrease during food deprivation and increase upon refeeding. Recently, we and others showed that OEA treatment in rodents protects against inflammatory events and changes the intestinal microbiota composition. In this review, we briefly define the role of OEA and of the gut microbiota in intestinal homeostasis and recapitulate recent findings suggesting an interplay between OEA and the intestinal microorganisms.
Keywords: dysbiosis; gut barrier permeability; inflammation; intestinal physiology; metabolic diseases; obesity.
Copyright © 2023 De Filippo, Costa, Becagli, Monroy, Provensi and Passani.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer LO declared a past co-authorship with the authors MP and CF to the Handling Editor.
Similar articles
-
Endocannabinoids--at the crossroads between the gut microbiota and host metabolism.Nat Rev Endocrinol. 2016 Mar;12(3):133-43. doi: 10.1038/nrendo.2015.211. Epub 2015 Dec 18. Nat Rev Endocrinol. 2016. PMID: 26678807 Review.
-
Intestinal GPR119 activation by microbiota-derived metabolites impacts feeding behavior and energy metabolism.Mol Metab. 2023 Jan;67:101649. doi: 10.1016/j.molmet.2022.101649. Epub 2022 Nov 30. Mol Metab. 2023. PMID: 36462626 Free PMC article.
-
Role of intestinal microbiota and metabolites on gut homeostasis and human diseases.BMC Immunol. 2017 Jan 6;18(1):2. doi: 10.1186/s12865-016-0187-3. BMC Immunol. 2017. PMID: 28061847 Free PMC article. Review.
-
The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MBP-0008-2014. Microbiol Spectr. 2015. PMID: 26185088
-
Effects of Alcohol Binge Drinking and Oleoylethanolamide Pretreatment in the Gut Microbiota.Front Cell Infect Microbiol. 2021 Nov 23;11:731910. doi: 10.3389/fcimb.2021.731910. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34888256 Free PMC article.
Cited by
-
Pharmacological potential of endocannabinoid and endocannabinoid-like compounds in protecting intestinal structure and metabolism under high-fat conditions.Front Pharmacol. 2025 May 22;16:1567543. doi: 10.3389/fphar.2025.1567543. eCollection 2025. Front Pharmacol. 2025. PMID: 40474970 Free PMC article. Review.
-
Targeting the Endocannabinoidome: A Novel Approach to Managing Extraintestinal Complications in Inflammatory Bowel Disease.Pharmaceuticals (Basel). 2025 Mar 27;18(4):478. doi: 10.3390/ph18040478. Pharmaceuticals (Basel). 2025. PMID: 40283915 Free PMC article. Review.
-
Eight-year diet and physical activity intervention affects serum metabolites during childhood and adolescence: A nonrandomized controlled trial.iScience. 2024 Jun 17;27(7):110295. doi: 10.1016/j.isci.2024.110295. eCollection 2024 Jul 19. iScience. 2024. PMID: 39055945 Free PMC article.
-
Differences in Microbial Community Structure Determine the Functional Specialization of Gut Segments of Ligia exotica.Microorganisms. 2025 Apr 2;13(4):808. doi: 10.3390/microorganisms13040808. Microorganisms. 2025. PMID: 40284644 Free PMC article.
-
Dietary iron interacts with diet composition to modulate the endocannabinoidome and the gut microbiome in mice.Gut Microbiome (Camb). 2025 Feb 14;6:e12. doi: 10.1017/gmb.2025.1. eCollection 2025. Gut Microbiome (Camb). 2025. PMID: 40692677 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical